血液OSC、OPG、NTX和尿液NTX的改变与乳腺癌骨转移治疗效果之间的关系研究(4)
[14] Telli M L. Phase Ⅱ Study of gemcitabine， carboplatin， and iniparib as neoadjuvant therapy for triple-negative and BRCA1/2 mutation-associated breast cancer with assessment of a tumorbased measure of genomic instability：PrECOG 0105[J].
J Clin Oncol，2015，33(17)：1895-1901.
[15] Joerger M，Huober J. Diagnostic and prognostic use of bone turnover markers[J].Recent Results Cancer Res，2012，19(2)：197-223.
[16] Kamby C，Egsmose C，Soletormos G，et al.The diagnostic and prognostic value of serum bone GLA protein (osteocalcin) in patients with recurrent breast cancer[J].Scand J Clin Lab Invest，2013，53(5)：439-446.
[17] Roodman G D. Genes associate with abnormal bone cell activity in bone metastasis[J].Cancer Metastasis Rev，2012，31(3-4)：569-578.
[18] Tamiya M，Suzuki H，Kobayashi M，et al.Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer[J].Med Oncol，2015，29(1)：215-218.
[19] Lee J S，Tung C H.Osteocalcin biomimic recognizes bone hydroxyapatite[J].Chembiochem，2011，12(11)：1669-1673., http://www.100md.com(邹燕鹏 孙宇 闻国权 张树平 钱朋飞 黎冠宏 刘丽红)
J Clin Oncol，2015，33(17)：1895-1901.
[15] Joerger M，Huober J. Diagnostic and prognostic use of bone turnover markers[J].Recent Results Cancer Res，2012，19(2)：197-223.
[16] Kamby C，Egsmose C，Soletormos G，et al.The diagnostic and prognostic value of serum bone GLA protein (osteocalcin) in patients with recurrent breast cancer[J].Scand J Clin Lab Invest，2013，53(5)：439-446.
[17] Roodman G D. Genes associate with abnormal bone cell activity in bone metastasis[J].Cancer Metastasis Rev，2012，31(3-4)：569-578.
[18] Tamiya M，Suzuki H，Kobayashi M，et al.Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer[J].Med Oncol，2015，29(1)：215-218.
[19] Lee J S，Tung C H.Osteocalcin biomimic recognizes bone hydroxyapatite[J].Chembiochem，2011，12(11)：1669-1673., http://www.100md.com(邹燕鹏 孙宇 闻国权 张树平 钱朋飞 黎冠宏 刘丽红)